Brought to you by:
Spotlight: SVS members take up new positions, make endowment
Sean Lyden, MD, is now chief medical consultant for VESTECK and has joined the VESTECK Scientific Advisory Board. VESTECK is an early-stage medical device company focused on the aortic repair and structural heart markets. Lyden chairs the Society for Vascular…
SVS Foundation board approves latest pilot programs to help underserved
The SVS Foundation has awarded grants to two Society for Vascular Surgery (SVS) members to help them serve the underserved as part of the Vascular Care for the Underserved program—the initiative formerly known as VISTA (Vascular Volunteers In Service To…
Sex found to be ‘important variable’ in study and treatment of carotid atherosclerosis
A systematic review and meta-analysis have demonstrated “convincing evidence” that sex differences exist in carotid atherosclerosis, with all types of plaque features—including those relating to size, composition, and morphology—found to be either larger or more common in men than in…
Vascular surgery oral boards text seeks to fill certifying void
Think of it as the omega of the vascular surgical textbook literature, quips Andrew M. Wishy, DO. As a training resource, it fits neatly on the trainee bookshelf on one side—the end to a partner title, The Vascular Surgery Review…
PRELUDE-BTK subanalysis highlights superior lumen gain, greater volumetric blood flow using serration angioplasty
Cagent Vascular has announced the results of a comparative subanalysis of the PRELUDE-below-the-knee (BTK) study versus plain balloon angioplasty. The study was led by Marianne Brodmann, MD, from Medical University of Graz in Graz, Austria. This subanalysis compared their PRELUDE-BTK…
Sudanese vascular association readies for first-ever conference
The Sudanese Association of Vascular Surgeons (SudAVaS) has announced the scientific program behind its first-ever international conference, marking the occasion by celebrating the “first steps in establishing vascular surgery as a standalone surgical specialty” in the northeast African country. The…
First patient enrolled in DEFIANCE trial of the ClotTriever system in DVT
Inari Medical announced that the first patient has been enrolled in DEFIANCE, a prospective randomized controlled trial (RCT) comparing the clinical outcomes of patients with iliofemoral deep vein thrombosis (DVT) treated with the ClotTriever system versus anticoagulation only. The trial is…
SVS Foundation: Get ‘Gatsby’ Gala tickets today
Tickets—both individual and for tables—are selling faster than a Gin Rickey during Prohibition for the Society for Vascular Surgery (SVS) Foundation’s “Great Gatsby Gala,” to be held at the 2023 Vascular Annual Meeting (VAM). From Feb. 3 to 18, individual…
VESAP5: Now up to 25% off
With the expiration of the fifth edition of the Vascular Education and Self-Assessment Program (VESAP5) in July, the Society for Vascular Surgery (SVS) is offering a discount of up to 25% on the program for a limited time. The discount…
NIH funding for vascular surgeon-scientists: ‘We need more funded vascular surgeons and better coverage of SVS priorities’
Presenting at the 2023 Southern Association for Vascular Surgery (SAVS) annual meeting in Rio Grande, Puerto Rico, Amin A. Mirzaie—a pre-medical student at Emory University in Atlanta—offered observations on the National Institutes of Health’s (NIH) “modestly” aligned vascular surgical funding…